ArticleTransplantation research2016

The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients.

Alina S R Zaltzman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.